Clinical implication of @entity419 PET/CT in XXXX .

@entity8984 @entity1 @entity419 @entity5 @entity2 @entity189 @entity3 @entity1086
The value of @entity419 positron emission tomography/computed tomography (FDG PET/CT) in the detection of @entity189 ( @entity189 ) differs among the studies. This study aimed to evaluate the role of @entity8984 -FDG PET/CT in @entity189 . Fifty-one @entity1 (19 @entity1 , 32 @entity1 ) with @entity3 confirmed by histopathology from an unknown @entity5 were included in this study. @entity1 received 370 MBq of @entity419 intravenously, and PET/CT was performed at 60 minutes after injection. Primary @entity5 sites were detected in 5 of 51 @entity1 (9.6%): in 2 @entity1 with @entity2 , in 1 @entity1 with @entity1086 , in 1 @entity1 with @entity189 , and in 1 @entity1 with @entity189 . No @entity5 was discovered in the remaining 46 @entity1 (90.4%) during the follow-up. The sensitivity, specificity, and accuracy of @entity8984 -FDG PET/CT were 100%, 80.4%, and 82.4%. The positive and negative predictive values were 35.7 and 100%, respectively. Based on the data presented, @entity8984 -FDG PET/CT has a clinical implicative value in detecting the @entity5 of @entity189 . PET/CT can be useful to rule out the possibility of detecting the @entity5 during the follow-up.
